Skip to main content

Treace Medical Concepts, Inc. (TMCI)

NASDAQ: TMCI · IEX Real-Time Price · USD
23.23 -1.23 (-5.01%)
Oct 21, 2021 1:20 PM EDT - Market open
Market Cap1.28B
Revenue (ttm)77.73M
Net Income (ttm)n/a
Shares Out49.19M
EPS (ttm)-0.26
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume113,794
Open24.50
Previous Close24.45
Day's Range22.87 - 24.76
52-Week Range22.43 - 37.17
Betan/a
Analystsn/a
Price Targetn/a
Est. Earnings DateNov 4, 2021

About TMCI

Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of device and/or biologic solutions for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical improvement. The company also provides Lapiplasty Mini-Incision precision system. In addition, it offers products to address ancillary surgical procedures, including akin osteotomies, weil os...

IndustryMedical Devices
IPO DateApr 23, 2021
Employees133
Stock ExchangeNASDAQ
Ticker SymbolTMCI
Full Company Profile

Financial Performance

In 2020, TMCI's revenue was $57.37 million, an increase of 45.54% compared to the previous year's $39.42 million. Losses were -$3.67 million, -14.00% less than in 2019.

Financial Statements

News

Treace to Report Third Quarter 2021 Financial Results on November 4, 2021

PONTE VEDRA, Fla., Oct. 14, 2021 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace”) (NasdaqGS: TMCI), a commercial-stage orthopaedic medical device company driving a paradigm shift in the surg...

6 days ago - GlobeNewsWire

Treace Announces New ALIGN3D™ Data at the 2021 AOFAS Annual Meeting

PONTE VEDRA, Fla., Sept. 23, 2021 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace”) (Nasdaq: TMCI), a commercial-stage orthopaedic medical device company driving a paradigm shift in the surgi...

3 weeks ago - GlobeNewsWire

Treace Announces Launch of Adductoplasty™ Instrumented Midfoot Correction System

PONTE VEDRA, Fla., Sept. 13, 2021 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace”) (Nasdaq: TMCI), a commercial-stage orthopaedic medical device company driving a paradigm shift in the surgi...

1 month ago - GlobeNewsWire

Treace Announces Participation in the Morgan Stanley 19th Annual Global Healthcare Conference

PONTE VEDRA, Fla., Sept. 02, 2021 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace”) (Nasdaq: TMCI), a commercial-stage orthopaedic medical device company driving a paradigm shift in the surgi...

1 month ago - GlobeNewsWire

Treace Announces New Supportive ALIGN3D™ Data to be Presented at the 2021 AOFAS Annual Meeting

PONTE VEDRA, Fla., Sept. 01, 2021 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace”) (Nasdaq: TMCI), a commercial-stage orthopaedic medical device company driving a paradigm shift in the surgi...

1 month ago - GlobeNewsWire

Treace Medical Concepts Reports Second Quarter 2021 Financial Results

PONTE VEDRA, Fla., Aug. 05, 2021 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a commercial-stage orthopaedic medical device company driving a paradigm ...

2 months ago - GlobeNewsWire

Treace to Report Second Quarter 2021 Financial Results on August 5, 2021

PONTE VEDRA, Fla., July 27, 2021 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace”) (NasdaqGS: TMCI), a commercial-stage orthopaedic medical device company driving a paradigm shift in the surg...

2 months ago - GlobeNewsWire

Treace Medical Concepts Reports First Quarter 2021 Financial Results

PONTE VEDRA, Fla., May 25, 2021 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a commercial-stage orthopaedic medical device company driving a paradigm s...

4 months ago - GlobeNewsWire

Treace Medical's Lapiplasty 3D Associated With Early Weightbearing After Foot Surgery, Interim Data Shows

Medical device company Treace Medical Concepts Inc (NASDAQ: TMCI) has announced interim results from the ALIGN3D clinical study, a post-market 5-year study designed to evaluate outcomes of Lapiplasty 3D...

5 months ago - Benzinga

Treace Announces Interim Results from ALIGN3D™ Clinical Study at ACFAS 2021

PONTE VEDRA, Fla., May 19, 2021 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace”) (Nasdaq: TMCI), a commercial-stage orthopaedic medical device company driving a paradigm shift in the surgica...

5 months ago - GlobeNewsWire

Treace to Report First Quarter 2021 Financial Results on May 25, 2021

PONTE VEDRA, Fla., May 18, 2021 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace”) (NasdaqGS: TMCI), a commercial-stage orthopaedic medical device company driving a paradigm shift in the surgi...

5 months ago - GlobeNewsWire

Treace to Announce Interim Results from ALIGN3D™ at ACFAS 2021

PONTE VEDRA, Fla., May 12, 2021 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace”) (Nasdaq: TMCI), a commercial-stage orthopaedic medical device company driving a paradigm shift in the surgica...

5 months ago - GlobeNewsWire

UPDATE - Treace Medical Concepts Announces Pricing of Upsized Initial Public Offering

PONTE VEDRA, Fla., April 22, 2021 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace”) (Nasdaq: TMCI), a commercial-stage orthopaedic medical device company driving a paradigm shift in the surgi...

5 months ago - GlobeNewsWire

Treace Medical Concepts Announces Pricing of Upsized Initial Public Offering

PONTE VEDRA, Fla., April 22, 2021 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace”) (Nasdaq: TMCI), a commercial-stage orthopaedic medical device company driving a paradigm shift in the surgi...

5 months ago - GlobeNewsWire

Treace Medical Concepts expects to raise $90.2 million in IPO

Ponte Vedra-based company plans to reach the market this week.

6 months ago - Jax Daily Record

Treace Medical Concepts IPO Registration Document (S-1)

Treace Medical Concepts, Inc. has filed to go public with an IPO on the NASDAQ.

6 months ago - SEC